Unichem Pharmaceuticals USA, Inc Discontinued
FDA Approved Drugs

Unichem Pharmaceuticals USA, Inc Discontinued

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Discontinued
  • Total Records 38
  • Latest Approval Date Sep 10, 2024
  • Data Source FDA
  • First Approval Date Jun 26, 2009
All
185
View
Discontinued
38
View
OTC
1
View
RX
146
View
Company Overview

Company

Unichem Pharmaceuticals USA, Inc Discontinued

Country

U.S.A

Website

Visit Website

Email

Social Profiles

Company Snapshot

Unichem Pharmaceuticals USA, Inc Discontinued

One Tower Center Blvd Suite 2200, East Brunswick, NJ 08816

U.S.A

www.unichemusa.com/ View on Map
FDA Approved Drug Records ( 38 records )
2021
17 Feb
Discontinued Application: 211819

Drug Name

APREMILAST

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2021-02-17

211819 / 1

Active Ingredient

APREMILAST

Application Number

211819

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2021-02-17

Regulatory Status

Discontinued

2021
17 Feb
Discontinued Application: 211819

Drug Name

APREMILAST

Product Number

2

Dosage Form

-

Strength

20MG

Approval Date

2021-02-17

211819 / 2

Active Ingredient

APREMILAST

Application Number

211819

Product Number

2

Dosage Form

-

Strength

20MG

Approval Date

2021-02-17

Regulatory Status

Discontinued

2021
17 Feb
Discontinued Application: 211819

Drug Name

APREMILAST

Product Number

3

Dosage Form

-

Strength

30MG

Approval Date

2021-02-17

211819 / 3

Active Ingredient

APREMILAST

Application Number

211819

Product Number

3

Dosage Form

-

Strength

30MG

Approval Date

2021-02-17

Regulatory Status

Discontinued

2021
12 Jan
Discontinued Application: 213301

Drug Name

CELECOXIB

Product Number

1

Dosage Form

-

Strength

50MG

Approval Date

2021-01-12

213301 / 1

Active Ingredient

CELECOXIB

Application Number

213301

Product Number

1

Dosage Form

-

Strength

50MG

Approval Date

2021-01-12

Regulatory Status

Discontinued

2021
12 Jan
Discontinued Application: 213301

Drug Name

CELECOXIB

Product Number

2

Dosage Form

-

Strength

100MG

Approval Date

2021-01-12

213301 / 2

Active Ingredient

CELECOXIB

Application Number

213301

Product Number

2

Dosage Form

-

Strength

100MG

Approval Date

2021-01-12

Regulatory Status

Discontinued

2021
12 Jan
Discontinued Application: 213301

Drug Name

CELECOXIB

Product Number

3

Dosage Form

-

Strength

200MG

Approval Date

2021-01-12

213301 / 3

Active Ingredient

CELECOXIB

Application Number

213301

Product Number

3

Dosage Form

-

Strength

200MG

Approval Date

2021-01-12

Regulatory Status

Discontinued

2021
12 Jan
Discontinued Application: 213301

Drug Name

CELECOXIB

Product Number

4

Dosage Form

-

Strength

400MG

Approval Date

2021-01-12

213301 / 4

Active Ingredient

CELECOXIB

Application Number

213301

Product Number

4

Dosage Form

-

Strength

400MG

Approval Date

2021-01-12

Regulatory Status

Discontinued

2009
26 Jun
Discontinued Application: 78680

Drug Name

CETIRIZINE HYDROCHLORIDE ALLERGY

Product Number

3

Dosage Form

-

Strength

5MG

Approval Date

2009-06-26

78680 / 3

Active Ingredient

CETIRIZINE HYDROCHLORIDE

Application Number

78680

Product Number

3

Dosage Form

-

Strength

5MG

Approval Date

2009-06-26

Regulatory Status

Discontinued

2009
26 Jun
Discontinued Application: 78680

Drug Name

CETIRIZINE HYDROCHLORIDE ALLERGY

Product Number

4

Dosage Form

-

Strength

10MG

Approval Date

2009-06-26

78680 / 4

Active Ingredient

CETIRIZINE HYDROCHLORIDE

Application Number

78680

Product Number

4

Dosage Form

-

Strength

10MG

Approval Date

2009-06-26

Regulatory Status

Discontinued

2024
10 Sep
Discontinued Application: 210507

Drug Name

CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

5MG;120MG

Approval Date

2024-09-10

210507 / 1

Active Ingredient

CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE

Application Number

210507

Product Number

1

Dosage Form

-

Strength

5MG;120MG

Approval Date

2024-09-10

Regulatory Status

Discontinued

2009
26 Jun
Discontinued Application: 78680

Drug Name

CETIRIZINE HYDROCHLORIDE HIVES

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2009-06-26

78680 / 1

Active Ingredient

CETIRIZINE HYDROCHLORIDE

Application Number

78680

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2009-06-26

Regulatory Status

Discontinued

2009
26 Jun
Discontinued Application: 78680

Drug Name

CETIRIZINE HYDROCHLORIDE HIVES

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2009-06-26

78680 / 2

Active Ingredient

CETIRIZINE HYDROCHLORIDE

Application Number

78680

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2009-06-26

Regulatory Status

Discontinued

2016
23 Jun
Discontinued Application: 203656

Drug Name

DONEPEZIL HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2016-06-23

203656 / 1

Active Ingredient

DONEPEZIL HYDROCHLORIDE

Application Number

203656

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2016-06-23

Regulatory Status

Discontinued

2016
23 Jun
Discontinued Application: 203656

Drug Name

DONEPEZIL HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2016-06-23

203656 / 2

Active Ingredient

DONEPEZIL HYDROCHLORIDE

Application Number

203656

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2016-06-23

Regulatory Status

Discontinued

2016
10 Nov
Discontinued Application: 204831

Drug Name

DONEPEZIL HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2016-11-10

204831 / 1

Active Ingredient

DONEPEZIL HYDROCHLORIDE

Application Number

204831

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2016-11-10

Regulatory Status

Discontinued

2016
10 Nov
Discontinued Application: 204831

Drug Name

DONEPEZIL HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2016-11-10

204831 / 2

Active Ingredient

DONEPEZIL HYDROCHLORIDE

Application Number

204831

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2016-11-10

Regulatory Status

Discontinued

2022
13 Oct
Discontinued Application: 213834

Drug Name

EXTENDED PHENYTOIN SODIUM

Product Number

1

Dosage Form

-

Strength

100MG EXTENDED

Approval Date

2022-10-13

213834 / 1

Active Ingredient

PHENYTOIN SODIUM

Application Number

213834

Product Number

1

Dosage Form

-

Strength

100MG EXTENDED

Approval Date

2022-10-13

Regulatory Status

Discontinued

2017
19 Sep
Discontinued Application: 207018

Drug Name

IRBESARTAN AND HYDROCHLOROTHIAZIDE

Product Number

1

Dosage Form

-

Strength

12.5MG;150MG

Approval Date

2017-09-19

207018 / 1

Active Ingredient

HYDROCHLOROTHIAZIDE; IRBESARTAN

Application Number

207018

Product Number

1

Dosage Form

-

Strength

12.5MG;150MG

Approval Date

2017-09-19

Regulatory Status

Discontinued

2017
19 Sep
Discontinued Application: 207018

Drug Name

IRBESARTAN AND HYDROCHLOROTHIAZIDE

Product Number

2

Dosage Form

-

Strength

12.5MG;300MG

Approval Date

2017-09-19

207018 / 2

Active Ingredient

HYDROCHLOROTHIAZIDE; IRBESARTAN

Application Number

207018

Product Number

2

Dosage Form

-

Strength

12.5MG;300MG

Approval Date

2017-09-19

Regulatory Status

Discontinued

2022
08 Aug
Discontinued Application: 212719

Drug Name

LABETALOL HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2022-08-08

212719 / 1

Active Ingredient

LABETALOL HYDROCHLORIDE

Application Number

212719

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2022-08-08

Regulatory Status

Discontinued

2022
08 Aug
Discontinued Application: 212719

Drug Name

LABETALOL HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

200MG

Approval Date

2022-08-08

212719 / 2

Active Ingredient

LABETALOL HYDROCHLORIDE

Application Number

212719

Product Number

2

Dosage Form

-

Strength

200MG

Approval Date

2022-08-08

Regulatory Status

Discontinued

2022
08 Aug
Discontinued Application: 212719

Drug Name

LABETALOL HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

300MG

Approval Date

2022-08-08

212719 / 3

Active Ingredient

LABETALOL HYDROCHLORIDE

Application Number

212719

Product Number

3

Dosage Form

-

Strength

300MG

Approval Date

2022-08-08

Regulatory Status

Discontinued

2017
13 Apr
Discontinued Application: 208340

Drug Name

PIROXICAM

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2017-04-13

208340 / 1

Active Ingredient

PIROXICAM

Application Number

208340

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2017-04-13

Regulatory Status

Discontinued

2017
13 Apr
Discontinued Application: 208340

Drug Name

PIROXICAM

Product Number

2

Dosage Form

-

Strength

20MG

Approval Date

2017-04-13

208340 / 2

Active Ingredient

PIROXICAM

Application Number

208340

Product Number

2

Dosage Form

-

Strength

20MG

Approval Date

2017-04-13

Regulatory Status

Discontinued

2018
19 Dec
Discontinued Application: 207011

Drug Name

PRAMIPEXOLE DIHYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

0.125MG

Approval Date

2018-12-19

207011 / 1

Active Ingredient

PRAMIPEXOLE DIHYDROCHLORIDE

Application Number

207011

Product Number

1

Dosage Form

-

Strength

0.125MG

Approval Date

2018-12-19

Regulatory Status

Discontinued

2018
19 Dec
Discontinued Application: 207011

Drug Name

PRAMIPEXOLE DIHYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

0.25MG

Approval Date

2018-12-19

207011 / 2

Active Ingredient

PRAMIPEXOLE DIHYDROCHLORIDE

Application Number

207011

Product Number

2

Dosage Form

-

Strength

0.25MG

Approval Date

2018-12-19

Regulatory Status

Discontinued

2018
19 Dec
Discontinued Application: 207011

Drug Name

PRAMIPEXOLE DIHYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

0.5MG

Approval Date

2018-12-19

207011 / 3

Active Ingredient

PRAMIPEXOLE DIHYDROCHLORIDE

Application Number

207011

Product Number

3

Dosage Form

-

Strength

0.5MG

Approval Date

2018-12-19

Regulatory Status

Discontinued

2018
19 Dec
Discontinued Application: 207011

Drug Name

PRAMIPEXOLE DIHYDROCHLORIDE

Product Number

4

Dosage Form

-

Strength

0.75MG

Approval Date

2018-12-19

207011 / 4

Active Ingredient

PRAMIPEXOLE DIHYDROCHLORIDE

Application Number

207011

Product Number

4

Dosage Form

-

Strength

0.75MG

Approval Date

2018-12-19

Regulatory Status

Discontinued

2018
19 Dec
Discontinued Application: 207011

Drug Name

PRAMIPEXOLE DIHYDROCHLORIDE

Product Number

5

Dosage Form

-

Strength

1MG

Approval Date

2018-12-19

207011 / 5

Active Ingredient

PRAMIPEXOLE DIHYDROCHLORIDE

Application Number

207011

Product Number

5

Dosage Form

-

Strength

1MG

Approval Date

2018-12-19

Regulatory Status

Discontinued

2018
19 Dec
Discontinued Application: 207011

Drug Name

PRAMIPEXOLE DIHYDROCHLORIDE

Product Number

6

Dosage Form

-

Strength

1.5MG

Approval Date

2018-12-19

207011 / 6

Active Ingredient

PRAMIPEXOLE DIHYDROCHLORIDE

Application Number

207011

Product Number

6

Dosage Form

-

Strength

1.5MG

Approval Date

2018-12-19

Regulatory Status

Discontinued

2017
07 Mar
Discontinued Application: 207835

Drug Name

RIZATRIPTAN BENZOATE

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

2017-03-07

207835 / 1

Active Ingredient

RIZATRIPTAN BENZOATE

Application Number

207835

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

2017-03-07

Regulatory Status

Discontinued

2017
07 Mar
Discontinued Application: 207835

Drug Name

RIZATRIPTAN BENZOATE

Product Number

2

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2017-03-07

207835 / 2

Active Ingredient

RIZATRIPTAN BENZOATE

Application Number

207835

Product Number

2

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2017-03-07

Regulatory Status

Discontinued

2017
07 Mar
Discontinued Application: 207836

Drug Name

RIZATRIPTAN BENZOATE

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

2017-03-07

207836 / 1

Active Ingredient

RIZATRIPTAN BENZOATE

Application Number

207836

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

2017-03-07

Regulatory Status

Discontinued

2017
07 Mar
Discontinued Application: 207836

Drug Name

RIZATRIPTAN BENZOATE

Product Number

2

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2017-03-07

207836 / 2

Active Ingredient

RIZATRIPTAN BENZOATE

Application Number

207836

Product Number

2

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2017-03-07

Regulatory Status

Discontinued

2018
04 May
Discontinued Application: 209261

Drug Name

VALSARTAN

Product Number

1

Dosage Form

-

Strength

40MG

Approval Date

2018-05-04

209261 / 1

Active Ingredient

VALSARTAN

Application Number

209261

Product Number

1

Dosage Form

-

Strength

40MG

Approval Date

2018-05-04

Regulatory Status

Discontinued

2018
04 May
Discontinued Application: 209261

Drug Name

VALSARTAN

Product Number

2

Dosage Form

-

Strength

80MG

Approval Date

2018-05-04

209261 / 2

Active Ingredient

VALSARTAN

Application Number

209261

Product Number

2

Dosage Form

-

Strength

80MG

Approval Date

2018-05-04

Regulatory Status

Discontinued

2018
04 May
Discontinued Application: 209261

Drug Name

VALSARTAN

Product Number

3

Dosage Form

-

Strength

160MG

Approval Date

2018-05-04

209261 / 3

Active Ingredient

VALSARTAN

Application Number

209261

Product Number

3

Dosage Form

-

Strength

160MG

Approval Date

2018-05-04

Regulatory Status

Discontinued

2018
04 May
Discontinued Application: 209261

Drug Name

VALSARTAN

Product Number

4

Dosage Form

-

Strength

320MG

Approval Date

2018-05-04

209261 / 4

Active Ingredient

VALSARTAN

Application Number

209261

Product Number

4

Dosage Form

-

Strength

320MG

Approval Date

2018-05-04

Regulatory Status

Discontinued

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    185 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
38 total
  • Discontinued
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

APREMILAST

Application Number

211819

Product Number

1

Active Ingredient

APREMILAST

Dosage Form

-

Strength

10MG

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit